Literature DB >> 21845110

Imaging utilization for the staging of clinically localized prostate cancer.

Stacy Loeb1, Alan W Partin.   

Abstract

Entities:  

Year:  2011        PMID： 21845110      PMCID： PMC3155872     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  4 in total

1.  Unnecessary imaging for the staging of low-risk prostate cancer is common.

Authors:  Hugh J Lavery; Jonathan S Brajtbord; Adam W Levinson; Fatima Nabizada-Pace; Matthew E Pollard; David B Samadi
Journal:  Urology       Date:  2010-10-08       Impact factor: 2.649

2.  Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006.

Authors:  Michaela A Dinan; Lesley H Curtis; Bradley G Hammill; Edward F Patz; Amy P Abernethy; Alisa M Shea; Kevin A Schulman
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

3.  Prostate specific antigen best practice statement: 2009 update.

Authors:  Kirsten L Greene; Peter C Albertsen; Richard J Babaian; H Ballentine Carter; Peter H Gann; Misop Han; Deborah Ann Kuban; A Oliver Sartor; Janet L Stanford; Anthony Zietman; Peter Carroll
Journal:  J Urol       Date:  2009-09-24       Impact factor: 7.450

4.  Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.

Authors:  Matthew R Cooperberg; Deborah P Lubeck; Gary D Grossfeld; Shilpa S Mehta; Peter R Carroll
Journal:  J Urol       Date:  2002-08       Impact factor: 7.450
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.